PCM
ABBV icon

Polymer Capital Management’s AbbVie ABBV Stock Holding History

Polymer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,160
Closed -$494K – 806
2025
Q4 		$494K Buy
2,160
+683
+46% +$156K 0.05% 467
2025
Q3 		$342K Buy
+1,477
New +$301K 0.04% 574

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polymer Capital Management's ABBV Position: Q1 2026 in Review

Polymer Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 2,160 shares — an estimated $494K sold.

Polymer Capital Management first reported a position in ABBV in Q3 2025 and held it in 2 quarters. The position peaked at $494K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Polymer Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Polymer Capital Management sold 2,160 AbbVie shares in Q1 2026, an estimated $494K.
  • Polymer Capital Management first reported a position in AbbVie in Q3 2025 and held it in 2 quarters.
  • Polymer Capital Management's AbbVie position peaked at $494K in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.